TSE:8795 stock news
This page provides real-time market news, earnings updates, and company announcements related to T&D Holdings, Inc. (TSE:8795).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-18 04:06 JST
Infrastructure Capital Announces a Quarterly Dividend Increase for: Infrastructure Capital Small Cap Income ETF (SCAP), Infrastructure Capital Equity Income ETF (ICAP)
Finviz2026-03-27 11:48:42
Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
Finviz2026-03-27 12:03:49
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights
Finviz2026-03-27 20:27:42
Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study
Finviz2026-03-30 11:03:47
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered "Depression Thermometer" Across its Interventional Psychiatry Network
Finviz2026-03-30 11:03:48
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-30 12:03:44
Companies Unveiling Autonomous Defense System Amid Surge Toward $43 Billion Global Market
Finviz2026-03-30 12:48:50
FLOWERS FOODS ANNOUNCES DEPARTURE OF CHIEF GROWTH OFFICER TERRY THOMAS
Finviz2026-03-30 13:03:04
CVS Pharmacy celebrates opening of first pharmacy-only location in Chicago
Finviz2026-03-30 16:03:49
McCormick to Combine with Unilever's Foods Business, Creating a Preeminent Global Flavor-Focused Company
Finviz2026-03-31 12:00:09
PEDEVCO Reports Fourth Quarter and Full-Year 2025 Results
Finviz2026-03-31 21:51:10
Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-04-01 21:03:44
Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response
Finviz2026-04-02 11:03:13
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte's TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
Finviz2026-04-02 11:06:06
Centene Announces New Executive Leadership Structure
Finviz2026-04-06 11:03:55
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Finviz2026-04-06 13:03:55
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
Finviz2026-04-07 11:06:54
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
Finviz2026-04-09 13:03:43
Steel Dynamics Announces First Quarter 2026 Earnings Conference Call and Webcast
Finviz2026-04-09 14:03:49
Xanadu Announces Fourth Quarter and Full Year 2025 Results
Finviz2026-04-09 21:09:02
Kornit Digital Redefines Apparel Production for the On-Demand Era Unveiling Atlas MATRIX at Konnections 2026
Finviz2026-04-12 22:03:06
Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL
Finviz2026-04-13 11:33:06
Palvella Therapeutics Appoints John D. Doux, M.D., M.B.A., Dermatologist and Recognized Leader in Rare Skin Diseases, to Board of Directors
Finviz2026-04-13 11:33:07
Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board
Finviz2026-04-14 11:03:57
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered "Depression Thermometer" Across its Interventional Psychiatry Network
Finviz2026-03-30 11:03:48
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-30 12:03:44
Companies Unveiling Autonomous Defense System Amid Surge Toward $43 Billion Global Market
Finviz2026-03-30 12:48:50
FLOWERS FOODS ANNOUNCES DEPARTURE OF CHIEF GROWTH OFFICER TERRY THOMAS
Finviz2026-03-30 13:03:04
CVS Pharmacy celebrates opening of first pharmacy-only location in Chicago
Finviz2026-03-30 16:03:49
McCormick to Combine with Unilever's Foods Business, Creating a Preeminent Global Flavor-Focused Company
Finviz2026-03-31 12:00:09
PEDEVCO Reports Fourth Quarter and Full-Year 2025 Results
Finviz2026-03-31 21:51:10
Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-04-01 21:03:44
Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response
Finviz2026-04-02 11:03:13
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte's TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
Finviz2026-04-02 11:06:06
Centene Announces New Executive Leadership Structure
Finviz2026-04-06 11:03:55
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Finviz2026-04-06 13:03:55
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
Finviz2026-04-07 11:06:54
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
Finviz2026-04-09 13:03:43
Steel Dynamics Announces First Quarter 2026 Earnings Conference Call and Webcast
Finviz2026-04-09 14:03:49
Xanadu Announces Fourth Quarter and Full Year 2025 Results
Finviz2026-04-09 21:09:02
Kornit Digital Redefines Apparel Production for the On-Demand Era Unveiling Atlas MATRIX at Konnections 2026
Finviz2026-04-12 22:03:06
Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL
Finviz2026-04-13 11:33:06
Palvella Therapeutics Appoints John D. Doux, M.D., M.B.A., Dermatologist and Recognized Leader in Rare Skin Diseases, to Board of Directors
Finviz2026-04-13 11:33:07
Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board
Finviz2026-04-14 11:03:57
TSE:8795 stock price change
On the last trading day, TSE:8795 stock closed at 4012.00 JPY, with a price change of -1.38% for the day.
Trade stock perpsTSE:8795 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more